Executive Summary
Keurig Dr Pepper’s QQ4 2024 results show a resilient top line with revenue of $4.07 billion, up 5.25% year over year and 4.60% quarter over quarter. Gross profit expanded to $2.278 billion, yielding a gross margin of approximately 55.9%. However, the quarter delivered a net loss of $144 million and negative earnings per share of $0.11, driven by a substantial load of other expenses and net non-operating items that more than offset EBITDA of $276 million and an operating income of $63 million. This combination underscores ongoing profitability pressures even as the company’s cash-generation capabilities remain solid on a operating basis.
From a liquidity and cash flow perspective, Keurig Dr Pepper generated $849 million in operating cash flow and $674 million in free cash flow, with capital expenditures totaling $175 million. Balance-sheet metrics show a cash balance of about $608 million and net debt of roughly $16.8 billion, reflecting a leveraged capital structure that continues to be a focal point for investors. While the business exhibits strong brand breadth and distribution scale, near-term profitability hinges on improving operating leverage, managing input costs, and executing on pricing and mix to offset elevated other expenses. The outlook will hinge on management’s ability to drive sustainable margin expansion while continuing to deploy cash flow toward deleveraging and shareholder-friendly activity.
Key Performance Indicators
QoQ: -93.02% | YoY:-93.32%
QoQ: -123.38% | YoY:-120.78%
QoQ: -124.44% | YoY:-122.00%
Key Insights
Revenue: $4,070.0 million; YoY +5.25%; QoQ +4.60%
Gross Profit: $2,277.0 million; YoY +4.26%; QoQ +6.40%
Operating Income: $63.0 million; YoY -93.32%; QoQ -93.02%
Net Income: -$144.0 million; YoY -120.78%; QoQ -123.38%
EPS: -$0.11; YoY -122.00%; QoQ -124.44%
EBITDA: $276.0 million; EBITDA Margin ≈ 6.78%
Net Profit Margin: -3.54%
Gross Margin: 55.9%
Operating Margin: 1.55%
Interest Expense: $247.0 million
Depreciation & Amortization: $183.0 million
Cash Flows (DSO/DSI)...
Financial Highlights
Revenue: $4,070.0 million; YoY +5.25%; QoQ +4.60%
Gross Profit: $2,277.0 million; YoY +4.26%; QoQ +6.40%
Operating Income: $63.0 million; YoY -93.32%; QoQ -93.02%
Net Income: -$144.0 million; YoY -120.78%; QoQ -123.38%
EPS: -$0.11; YoY -122.00%; QoQ -124.44%
EBITDA: $276.0 million; EBITDA Margin ≈ 6.78%
Net Profit Margin: -3.54%
Gross Margin: 55.9%
Operating Margin: 1.55%
Interest Expense: $247.0 million
Depreciation & Amortization: $183.0 million
Cash Flows (DSO/DSI): Operating cash flow $849.0 million; Free cash flow $674.0 million; Capex $(175.0) million; Net change in cash $48.0 million
Balance Sheet (period end): Total assets $53.43B; Cash & equivalents $0.61B; Total debt $17.27B; Net debt $16.76B; Total current liabilities $8.09B; Total stockholders’ equity $24.24B
Liquidity: Current ratio 0.49; Quick ratio 0.32; Cash ratio 0.07
Key leverage: Debt to capitalization ~0.417; Debt to equity ~0.714; Interest coverage ~5.4
Income Statement
| Metric |
Value |
YoY Change |
QoQ Change |
| Revenue |
4.07B |
5.25% |
4.60% |
| Gross Profit |
2.28B |
4.26% |
6.40% |
| Operating Income |
63.00M |
-93.32% |
-93.02% |
| Net Income |
-144.00M |
-120.78% |
-123.38% |
| EPS |
-0.11 |
-122.00% |
-124.44% |
Key Financial Ratios
operatingProfitMargin
23%
operatingCashFlowPerShare
$0.63
freeCashFlowPerShare
$0.5
dividendPayoutRatio
-216%
Management Commentary
Earnings call transcript not provided in the dataset. Therefore, a synthesis of management commentary and quotes from the QQ4 2024 call cannot be shown here. If a transcript becomes available, I will add them grouped by themes (strategy, operations, market conditions) with context and significance.
Forward Guidance
No formal forward-looking guidance is included in the provided data. Given the cadence of revenue growth alongside a material negative net income, the near-term outlook will depend on several factors: (1) price realization and product-mix optimization to improve gross margins; (2) continued control of selling, general, and administrative costs and other operating expenses; (3) ongoing benefits from efficiency initiatives and any incremental cost synergies from brand investments; (4) commodity and freight cost dynamics; (5) cash flow generation to support deleveraging and capital allocation. Management commentary (when available) would need to confirm targets for margin expansion, throughput of price increases, and capex intensity. Monitoring key variables such as gross margin progression, SG&A as a percentage of revenue, and FCF conversion relative to net income will be critical to gauge progress toward a healthier earnings trajectory.